ORONA, Calif., Dec. 29 (HSMN NewsFeed) — Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leader in generic and specialty branded pharmaceuticals, today announced that its subsidiary, Watson Laboratories, Inc., has received final approval from the United St…
Biopharmaceuticals, FDA, Generics
Watson Pharmaceuticals, Watson Laboratories, Duramed Pharmaceuticals, Mircette

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)”
Leave a Comment